Multiple myeloma associated with porphyria cutanea tarda: A possible role of bortezomib? [1]

Dermatology

Volumn 213, Issue 3, 2006, Pages 246-247

  Cabanillas, Miguel ^a,b   Peteiro, Carmen ^a   Toribio, Jaime ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Bortezomib; Multiple myeloma; Non alcoholic hepatic steatosis; Phenytoin; Porphyria cutanea tarda

Indexed keywords

ALPHA INTERFERON; BORTEZOMIB; CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PHENYTOIN; PREDNISONE; THALIDOMIDE; VINCRISTINE;

AGED; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; MULTIPLE MYELOMA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; SKIN BIOPSY; VESICULAR RASH;

AGED; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; FEMALE; HUMANS; MULTIPLE MYELOMA; PORPHYRIA CUTANEA TARDA; PYRAZINES;

EID: 33750017043     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095047     Document Type: Letter

References (8)

1. Dandurand M, Guillot B, Guilhou JJ: Porphyrie cutanée tardive et néoplasies. A propos de deux observations. Ann Dermatol Venereol 1986;113:679-683.
2. McKenna DB, Browne M, O'Donell R, Murphy GM: Porphyria cutanea tarda and hematologic malignancy (a report of 4 cases). Photodermatol Photoimmunol Photomed 1997;13:143-146.
3. Barzilay D, Orion E, Brenner S: Porphyria cutanea tarda triggered by a combination of three predisposing factors. Dermatology 2001;203:195-197.
4. Fernandez Y, Miller TP, Denoyelle C, Esteban JA, Tang WH, Bengtson AL, Soengas MS: Chemical blockage of the proteasome inhibitory function of Bortezomib: impact on tumor cell death. J Biol Chem 2006;281:1107-1118.
5. Rajkumar SV, Richardson PG, Hideshima T, Anderson KC: Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol 2005;23:630-639.
6. Korsmeyer KK, Davoll S, Figueiredo-Pereira ME, Almira Correia M: Proteolytic degradation of heme-modified hepatic cytochromes P450: a role for phosphorylation, ubiquitination, and the 26S proteasome? Arch Biochem Biophys 1999;365:31-44.
7. Sinclair PR, Gorman N, Tsylov IB, Fuhr U, Walton HS, Sinclair JF: Uroporphyrinogen oxidation catalyzed by human cytochromes P450. Drug Metab Dispos 1998;26:1019-1025.
8. De Matteis F: Porphyria cutanea tarda of the toxic and sporadic varieties. Clin Dermatol 1998;16:265-275.